A noninvasive cell-based assay for monitoring proteolytic activity within a specific subcellular compartment

被引:8
作者
Belkhiri, A [1 ]
Lytvyn, V [1 ]
Guilbault, C [1 ]
Bourget, L [1 ]
Massie, B [1 ]
Nägler, DK [1 ]
Ménard, R [1 ]
机构
[1] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada
关键词
D O I
10.1006/abio.2002.5706
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
A noninvasive cell-based assay has been developed to monitor the proteolytic activity of cathepsin L within a specific subcellular compartment, the lysosome. The green fluorescent protein (GFP) of Aequorea victoria was selected as a substrate. Targeting to lysosomes was achieved by fusing GFP to preprocathepsin L, which also ensures colocalization of the enzyme and the substrate. Stably transfected HeLa-rtTA (reverse tetracycline-controlled transactivator) cells were induced with doxycycline and cultured in the presence of various concentrations of cysteine protease inhibitors for 48 h. In the absence of inhibitor, proteolytic degradation of GFP leads to loss of fluorescence, which is due almost exclusively to the action of recombinant cathepsin L. However, a dose-dependent increase of GFP fluorescence is observed for cells treated with the potent cathepsin L inhibitor benzyloxycarbonyl-LeuLeuTyr-CHN2. Fluorescence is also observed when GFP is fused to an inactive preprocathepsin L (C25A mutant). Targeting of GFP to an acidic cellular compartment can destabilize the protein and render it susceptible to proteolytic degradation. The approach should be generally applicable for proteases localized in acidic environments. Such an assay can be of great value in validating the participation of a specific enzyme in a given process or in testing the ability of putative inhibitors to reach their intracellular target.
引用
收藏
页码:237 / 246
页数:10
相关论文
共 35 条
[1]
Transferrin Trojan horses as a rational approach for the biological delivery of therapeutic peptide domains [J].
Ali, SA ;
Joao, HC ;
Hammerschmid, F ;
Eder, J ;
Steinkasserer, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (34) :24066-24073
[2]
INACTIVATION OF CALPAIN BY PEPTIDYL FLUOROMETHYL KETONES [J].
ANGLIKER, H ;
ANAGLI, J ;
SHAW, E .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (02) :216-220
[3]
BARRETT AJ, 1998, HDB PROTOEOLYTIC ENZ
[4]
RENATURATION OF AEQUOREA GREEN-FLUORESCENT PROTEIN [J].
BOKMAN, SH ;
WARD, WW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1981, 101 (04) :1372-1380
[6]
Cysteine proteases as therapeutic targets [J].
Brömme, D .
DRUG NEWS & PERSPECTIVES, 1999, 12 (02) :73-82
[7]
Phospholipase D1 localises to secretory granules and lysosomes and is plasma-membrane translocated on cellular stimulation [J].
Brown, FD ;
Thompson, N ;
Saqib, KM ;
Clark, JM ;
Powner, D ;
Thompson, NT ;
Solari, R ;
Wakelam, MJO .
CURRENT BIOLOGY, 1998, 8 (14) :835-838
[8]
Bühling F, 2000, ADV EXP MED BIOL, V477, P241
[9]
Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases [J].
Carmona, E ;
Dufour, E ;
Plouffe, C ;
Takebe, S ;
Mason, P ;
Mort, JS ;
Menard, R .
BIOCHEMISTRY, 1996, 35 (25) :8149-8157
[10]
In vivo assay for hepatitis C viral serine protease activity using a secreted protein [J].
Cho, YG ;
Yang, SH ;
Sung, YC .
JOURNAL OF VIROLOGICAL METHODS, 1998, 72 (01) :109-115